Lineage Logistics Strengthens Industry-Leading Temperature-Controlled Facility Network in Europe With a Dozen Transactions in 2020
1.2.2021 22:08:00 EET | Business Wire | Press release
Lineage Logistics, LLC (“Lineage” or the “Company”), the world’s largest and most innovative temperature-controlled industrial REIT and logistics solutions provider, today announced the completion of twelve transactions across Europe to build on its leading global facility network. Over the past twelve months, Lineage completed strategic acquisitions across four countries that consists of twenty locations in core population and food production markets. Also included in the Company’s deal activity is a majority investment in a state-of-the art automation commissioning business located in Belgium. All acquisitions have either been successfully integrated or will be integrated in the first quarter of 2021.
Among the companies joining the Lineage team is Coldstar, Lineage’s most recent acquisition in the region which features a highly automated operation in the “Golden Triangle” of Denmark, strategically located between Jutland, Zealand and Germany. Coldstar adds nearly seven million cubic feet and over 20,000 pallet positions of cold storage capacity to the Lineage network, with more than 100 skilled and enthusiastic team members serving approximately 65% of the Danish retail market. Plans to grow this business and expand its offerings to retailers in Denmark and beyond are actively under consideration.
In addition to Coldstar, the announced transactions include:
Denmark
- Lundsøe Køl og Frys, five locations across Denmark with a substantial expansion planned for the Port of Aarhus to be completed in 2021
- Super Frost Sjaelland A/S, one location outside Copenhagen
- Kolding, one triple-net leased facility
- Kanalholmen, one triple-net leased facility
The Netherlands
- Vriescentrale Asten, one highly automated operation focused on meat processing for international export
- Frigo Group’s Heerenberg B.V. location in Heerenberg
Belgium
- F.A.I.S. - Flexible Automation Innovative Solutions – a state-of-the-art automation commissioning business that will assist Lineage in its substantial new build growth pipeline
Norway
- Larvik, one net leased facility in proximity to Larvik Harbour, Norway’s second largest container port
- Oslo, one net leased facility
- Moss Cold Storage, one operation in Moss, Norway that services the broader Norwegian market
Poland
- Pago Sp. z o.o., six locations across Poland
“In a year like 2020, which presented both challenges and opportunities, I’m proud we were able to enter new markets and continue our growth momentum around the globe,” said Greg Lehmkuhl, President and Chief Executive Officer of Lineage. “We ended the year in a strong position in the European market and more focused than ever on our purpose of transforming the food supply chain to eliminate waste and help feed the world.”
“These transactions are important to our growing European footprint and address increasing demand from customers to respond to shifting market dynamics and implement new, innovative and global supply chain solutions,” said Mike McClendon, Lineage’s President of International Operations & EVP of Network Optimization. “The strategic locations of these facilities, combined with those which offer and facilitate highly-automated operations or expansion opportunities, allow us to offer supply chain solutions that extend throughout the entire value chain.”
Following the close of these transactions, the combined Company features a global footprint that spans over 2.1 billion cubic feet of temperature-controlled capacity across over 340 facilities in 15 countries spanning North America, Europe, Asia, Australia, New Zealand, and South America.
About Lineage Logistics
Lineage is the world’s largest and most innovative temperature-controlled industrial REIT and logistics solutions provider, its unrivaled real estate network, and its use of technology combine to promote food safety, increase distribution efficiency, advance sustainability, lessen environmental impact, and minimize supply chain waste. As a result, Lineage helps customers ranging from Fortune 500 companies to small family-owned businesses increase the efficiency and protect the integrity of their temperature-controlled supply chain. Lineage has grown its cubic feet by 60% annually since 2008 to 2.1 billion cubic feet, making it the largest global temperature-controlled industrial REIT. In recognition of the company’s leading innovations, Lineage was recognized as the No 1. Data Science company on Fast Company’s Annual list of The World’s Most Innovative Companies in 2019, in addition to ranking 23rd overall in an evaluation of thousands of companies worldwide. (www.lineagelogistics.com)
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210201005802/en/
Contact information
Lineage Logistics
Megan Hendricksen
949.247.5172
mhendricksen@lineagelogistics.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Techtronic Industries Delivers Strong First Half Performance4.8.2026 14:20:00 EEST | Press release
Techtronic Industries Co. Ltd. (“TTI” or the “Group”) (stock code: HK: 0669, ADR symbol: TTNDY), a global cordless power tool, outdoor power equipment and floorcare & cleaning company, is pleased to announce its results for the six-month period ended June 30, 2026. The Group delivered record first half results in 2026, with revenue growing 5.9% to US$8.3 billion. Its two leading brands, MILWAUKEE and RYOBI, both delivered a strong performance in the first half of 2026, growing at a combined 8.2% underlying growth rate in local currency. TTI delivered record first half results in 2026, with revenue growing 5.9% to US$8.3 billion and net profit increasing 17.5% to US$738 million. Our global MILWAUKEE business grew 10.5% on an underlying basis in local currency, after adjusting for the planned 2025 timing impact related to the MILWAUKEE Americas ERP system conversion. RYOBI, the #1 global consumer cordless tool and outdoor products brand, grew 1.7% in local currency to US$1.9 billion in t
WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership4.8.2026 12:00:00 EEST | Press release
WHOOP, the human performance company, today announced an expansion of its women’s health offering through an integration with Natural Cycles° (NC°), the only FDA-cleared, hormone-free birth control app. WHOOP is offering a 12-month subscription to the NC° app to eligible new Natural Cycles users. Members with compatible WHOOP devices can now automatically share overnight skin temperature with the NC° app to enable personalized fertility insights and hormone-free birth control. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260804399367/en/ WHOOP Expands Commitment to Women's Health by Including One-Year Subscription of Natural Cycles° App in Membership The Natural Cycles app, a Class II medical device, uses biomarker data, including temperature and heart rate data, to identify fertile and non-fertile days, helping users prevent pregnancy without hormones while also providing fertility insights. Beyond birth control, the app
Alphatax Makes Two Acquisitions to Strengthen Transfer Pricing Capabilities4.8.2026 11:00:00 EEST | Press release
Alphatax, the global tax compliance software provider, has today announced the acquisitions of TP Accurate and Intra Pricing Solutions, expanding its transfer pricing capabilities and reinforcing its ambition to build the world's first tax operating system. The acquisitions strengthen Alphatax's transfer pricing portfolio with complementary capabilities across financial transactions and documentation. TP Accurate provides specialist software for intra-group financing arrangements, while Intra Pricing Solutions' flagship product, TPGenie, enables multinational organisations and advisors to produce transfer pricing documentation using intelligent automation and AI. Together, they expand Alphatax's ability to support the full transfer pricing lifecycle, helping customers manage compliance more efficiently while improving governance and reducing audit risk. They also represent another step towards Alphatax's long-term vision for the future of tax technology. By bringing these transfer pric
LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Care4.8.2026 10:10:00 EEST | Press release
LabPMM®, an Invivoscribe® subsidiary, today announced the global availability of its new KMT2A measurable residual disease (MRD) testing service. The highly sensitive digital PCR service is available to healthcare providers, clinical researchers, and biopharmaceutical partners through LabPMM’s global laboratory network, with CAP/CLIA-accredited testing available in the U.S. The service addresses a growing need for accurate molecular monitoring in acute leukemias.1,2,3 KMT2A rearrangements (KMT2Ar) are oncogenic drivers in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).4 These rearrangements are present in about 80% of infant cases and 5-15% of childhood and adult leukemia cases.5 KMT2Ar leukemias are associated with chemotherapy resistance, high relapse rates, and poor clinical outcomes.5 The emergence of menin inhibitors is transforming the therapeutic landscape for patients with AML and ALL, particularly those with KMT2A-rearranged and NPM1-mutated disease.6 The
Mosaic Therapeutics appoints Dr Allison Jeynes as Chair of the Board4.8.2026 10:00:00 EEST | Press release
Mosaic Therapeutics, Ltd, (‘Mosaic’, or ‘the Company’) an oncology therapeutics company developing novel, targeted drug combinations across a range of haematological and solid cancers, today announced the appointment of Dr Allison Jeynes as Chair of the Board to support its next phase of growth and advancement towards clinical development. Allison succeeds Dr Edward Hodgkin, who remains a Non-Executive Director of the Board. Allison is a UK-trained oncologist and highly-experienced life sciences leader, and brings over three decades of drug development and executive experience to Mosaic Therapeutics. As CEO of Avillion, a clinical development company, for the last 13 years, she has led global teams to achieve a 100% success rate from Phase 3 development through to FDA approval for multiple programs spanning oncology, immunology and respiratory medicine. In addition, she raised funds of around $400M as founder and CEO. Across her career she has contributed to 20 drug approvals, engaging
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
